febuxostat / Generic mfg. 
Welcome,         Profile    Billing    Logout  

79 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
febuxostat / Generic mfg.
ACTRN12612000434897: To compare the efficacy & safety profile of Febuxostat with Allopurinol in local Pakistani hyperuricemic patients.

Recruiting
4
120
 
PharmEvo (Pvt.) Ltd., PharmEvo (Pvt.) Ltd.
Hyperuricemia, Gout
 
 
ACTRN12616000959471: A multicentre study of the dose concentration response of febuxostat in patients with chronic gout.

Recruiting
4
120
 
St Vincent's Hospital, Clinical Pharmacology Lexy Davies Trust Fund
Gout
 
 
ChiCTR-TTRCC-14005168: Pharmacokinetics and Tolerability of Febuxostat Tablets after Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose Study

Completed
4
36
 
administer febuxostat 40mg as a single dose (day1) and multiple doses (days 4–9) ;administer febuxostat 80mg as a single dose (day1) and multiple doses (days 4–9) ;received a single dose of 120mg febuxostat
the First Affiliated Hospital, College of Medicine, Zhejiang University; None, Zhejiang Jianfeng Pharmaceutical CO., LTD
Healthy Volunteers
 
 
2011-001883-23: Febuxoststat versus Allopurinol Steamlined Trial (FAST)

Ongoing
4
4706
Europe
Feboxostat Trade Name: Adenuric, Allopurinol, Adenuric, Allopurinol, Adenuric, Allopurinol
University of Dundee, , Menarini
Chronic symptomatic hyperuricaemic
 
 
2012-001858-25: A clinical study on the therapeutic efficacy and safety of Febuxostat and Allopurinol on serum urate concentration in subjects suffering from hyperuricemia and gout

Ongoing
4
330
Europe
Febuxostat, Allopurinol, Colchicine, ADENURIC, ZYLORIC, Colchicina Lirca, ADENURIC, ZYLORIC, Colchicina Lirca
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A., MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A., MIOL - Menarini International Operations Luxembourg S.A.
hyperuricemia and gout
 
 
ChiCTR-IPR-17011837: The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese asymptomatic hyperuricemic patients with chronic kidney disease

Recruiting
4
100
 
febuxostat ;allopurinol
the Affiliated Hospital of Qingdao University; the Affiliated Hospital of Qingdao University, raise independently
Hyperuricemia
 
 
ChiCTR1800019352: A randomized controlled open-label trial for the efficacy and safety of low dose febuxostat and benzbromarone in gout patients

Completed
4
240
 
febuxostat 20mg/d p.o. + sodium bicarbonate 1g qd p.o. ;benzbromarone 25mg qd p.o. + sodium bicarbonate 1g qd p.o.
the Affiliated Hospital of Qingdao University; the Affiliated Hospital of Qingdao University, The study of molecular typing of gout based on omics characteristic spectrum
gout
 
 
ChiCTR1800018160: Comparison of the efficacy of fenofibrate combined with febustat and benzbromarone in the treatment of gout with hypertriglyceridemia

Recruiting
4
804
 
Febuxostat + fenofibrate: febuxostat 20mg / day + fenofibrate capsule 200mg /day, oral,at breakfast ;Benzobromide tablets + fenofibrate: benzbromarone 25mg /day + fenofibrate capsules 200mg / day, oral,at breakfast
Affiliated Hospital of Qingdao University; Affiliated Hospital of Qingdao University,Shandong Gout Clinical Medical Center, Provided by the tester
gout
 
 
ChiCTR1800020310: The effects of febuxostat versus allopurinol on oxidative stress in Chinese asymptomatic hyperuricemic patients with chronic kidney disease

Recruiting
4
371
 
febuxostat ;allopurinol ;none
the Affiliated Hospital of Qingdao University; the Affiliated Hospital of Qingdao University, raise independently
Hyperuricemia
 
 
ChiCTR-RIC-17011687: A single-center, prospective cohort study of the effects of Febuxostat Tablets on insulin resistance and islet beta cells function in patients with hyperuricemia with different glucose metabolic status

Not yet recruiting
4
120
 
patients treated with Febuxostat Tablets ;patients treated without Febuxostat Tablets
Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Jiangsu Hengrui pharmaceutical Limited by Share Ltd
hyperuricemia
 
 
ChiCTR1800017922: Effects of Febuxostat on improving glucose and lipid metabolic, and anti-arteriosclerosis in asymptomatic hyperuricemia patients

Recruiting
4
300
 
Only have low purine diet ;take febuxostat orally
The Affiliated Huai'an 1st People's Hospital of Nanjing Medical University; The Affiliated Huai'an 1st People 's Hospital of Nanjing Medical University, Enterprises aid research
Asymptomatic hyperuricemia
 
 
ChiCTR1900028169: A clinical study for febuxostat with stepwise dose in the prevention of gout flares

Recruiting
4
275
 
stepwise dose increase of febuxostat ;febuxostat+colchicine ;febuxostat40mg/d
Anqing Hospital Affiliated to Anhui Medical University; Anqing Hospital Affiliated to Anhui Medical University, Scientific research foundation of anhui medical university
Gout
 
 
ChiCTR1900021469: The effect of febuxostat in Tibetan gout patients: An observational study

Recruiting
4
70
 
Hospital of the People's Government of Tibet Autonomous Region in Chengdu Office; Hospital of the People's Government of Tibet Autonomous Region in Chengdu Office, planning funds offered by Sichuan provincial health and family planning commission and supporting funds offered by ourself hospital
gout and uric acid
 
 
ChiCTR1800015509: Clinical Study on the Treatment of simple Obesity with Hyperuricemia by Febuxostat Tablets

Recruiting
4
150
 
febuxostat tables ;Lifestyle
Chengdu University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine, JIANG SU HENG RUI MEDICINE CO,.LTD
simple obesity with asymptomatic hyperuricemia
 
 
2020-005730-15: Research into continuation or cessation of urate lowering therapies in gout patients in remission. Onderzoek met urinezuurverlagende therapie bij jicht. Levenslang doorgaan of is (tijdelijk) stoppen mogelijk?

Ongoing
4
310
Europe
Tablet, Allopurinol, Desuric, Adenuric
Sint Maartenskliniek, ZonMw /ZE&GG, Sint Maartenskliniek
Gout, arthritis urica, Gout, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2020-005721-82: The Gout TrEatment STrategy Project (GO TEST) Overture trial

Ongoing
4
310
Europe
Tablet, Zyloric, Adenuric 80 mg, Desuric
VieCuri, ZonMW, ReumaNederland
gout, gout, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
ChiCTR2100044828: Effects of different types of uric acid lowering drugs on gout flare

Recruiting
4
150
 
febuxostat(40mg/d,4 weeks) or allopurinol (200mg/d, 4 weeks) ;benzbromarone(50mg/d,4 weeks)
The First Affiliated Hospital of University of Science and Technology of China; The First Affiliated Hospital of University of Science and Technology of China, The patient bears the cost of the test
Gout
 
 
ChiCTR2000034138: Randomized, double-blind, double-simulated, parallel-controlled clinical trials of the efficacy and safety of Medicinal Charcoal Tablets in the treatment of primary gout with hyperuricemia

Not yet recruiting
4
168
 
Febuxostat 20mg, 2 tablets, qd; medicinal carbon tablets analog, 8 tablets, tid; oral ;Febuxostat 20mg, 1 tablet, febuxostat analog tablet, 1 tablet, qd; medicinal carbon tablets, 5 tablets, medicinal carbon tablets analog, 3 tablets, tid; oral ;Febuxostat 20mg, 1 tablet, febuxostat analog tablet, 1 tablet, qd;medicinal carbon tablets, 8 tablets, tid; oral ;Febuxostat 20mg, 1 tablet, febuxostat analog tablet, 1 tablet, qd; medicinal carbon tablets analog, 8 tablets, tid; oral
Affiliated Hospital of Qiingdao University; Affiliated Hospital of Qingdao University, Provided by the tester
gout
 
 
ChiCTR2200067196: Effect of diffrent dose of febuxostat on renal function in elderly patients with chronic kidney disease and hyperuricemia

Completed
4
120
 
Febuxostat 20 mg/d ;Febuxostat 40 mg/d ;Diet and lifestyle intervention
Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital, Self-funded
hyperuricemia
 
 
ChiCTR2000038289: A randomized, controlled, single center clinical trial of total glucosides of paeony in the prevention of gout

Recruiting
4
120
 
Paeonia total glycosides capsule 0.6g Tid ;Blank control group ;Febuxostat capsules 20mg Qd + total glucosides of paeony capsules 0.6g tid ;Febuxostat capsules 20mg Qd
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Department of Rheumatology and Immunology; The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Ningbo Lihua Pharmaceutical Co., Ltd.
Gout
 
 
ChiCTR2100042424: The efficacy and safety of chitosan oligosaccharide in treatment of Chinese primary gout with hyperuricemia patients: a prospective, randomized controlled study

Recruiting
4
150
 
Febuxostat 20mg qd, placebo 6g, bid ;Febuxostat 20mg qd, Kesuanping 6g, bid
Affiliated Hospital of Qiingdao University; Affiliated Hospital of Qiingdao University, Provided by the Sponsor
gout
 
 
ChiCTR2100050749: Comparative study on the effectiveness of tart cherry citrate effervescent tablets, citrate effervescent tablets and sodium bicarbonate in alkalizing urine of patients with primary gout with hyperuricemia

Recruiting
4
270
 
Febuxostat 20mg qd + citrate effervescent tablets 3.5g bid (initial treatment); Febuxostat 40mg qd + citrate effervescent tablets 3.5g bid (adjusted based on urate level) ;Febuxostat 20mg qd + sodium bicarbonate 1g tid (initial treatment); Febuxostat 40mg qd + sodium bicarbonate 1g tid (adjusted based on urate level) ;Febuxostat 20mg qd + tart cherrycitrate effervescent tablets 3.5g bid (initial treatment); Febuxostat 40mg qd + tart cherry citrate effervescent tablets 3.5g bid (adjusted based on urate level)
Affiliated Hospital of Qiingdao University; Affiliated Hospital of Qingdao University, Provided by the tester
gout
 
 
ChiCTR2000035778: Long-term safety of urate-lowering drugs and their protective effects on important organs

Not yet recruiting
4
450
 
Allopurinol is recommended to start at 100mg and 50mg for patients with renal insufficiency ;Febuxostat start at 20mg ;Benzbromarone start at 25mg
Huashan Hospital, Fudan University; Huashan Hospital, Fudan University, Shanghai Shenkang Hospital Development Center
Gout/Hyperuricemia
 
 
2021-002185-40: Allopurinol and Febuxostat Treatment in Patients with Adenine Phosphoribosyltransferase Deficiency: A Clinical Trial

Ongoing
4
10
RoW
Tablet, Uloric, Allopurinol Alvogen
Landspitali - The National University Hospital of Iceland, Icelandic Research Fund
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency is a hereditary disorder causing kidney stones and kidney failure in untreated patients., Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
 
 
IMPULsKF, NCT03336203: The Impact of Urate-lowering Therapy on Kidney Function

Enrolling by invitation
4
2
RoW
Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral Tablet
Medical Practice Prof D. Ivanov
Gout, CKD Stage 1-4, SUA Level (>8 mg/dL; 480 µmol/L)
12/22
12/22
LUMINA, NCT03200210: Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients

Recruiting
4
548
RoW
Febuxostat, Febuxostat Tablets, Placebo
Sun Yat-sen University
Hyperuricemia
12/22
12/22
ChiCTR2200055197: Comparative trial on effectiveness and safety of benzbromarone and febuxostat in lower-urate therapy of gout patients with combined types

Recruiting
4
250
 
Febuxostat 25mg qd + citrate mixture 3.5g bid (initial treatment); Febuxostat 40mg qd + citrate mixture 3.5g bid(adjusted based on urate level) ;Febuxostat 25mg qd + citrate mixture 3.5g bid (initial treatment); Febuxostat 40mg qd +benzbromarone 25mg qd + citrate mixture 3.5g bid(adjusted based on urate level)
Affiliated hospital of Qingdao University; Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases
gout
 
 
NCT05474560: Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Completed
4
90
RoW
Allopurinol (100 mg/day) plus lifestyle intervention, Allopurinol group, Febuxostat 40 mg plus lifestyle intervention, Febuxostat group, Life style intervention
Ain Shams University
Non-Alcoholic Fatty Liver Disease, Hyperuricemia
01/23
01/23
ChiCTR2200066023: Clinical trial of Aixite medicinal charcoal tablets in preventing acute attack during the treatment of primary gout and reducing uric acid

Not yet recruiting
4
300
 
Febuxostat 40mg+medicinal carbon tablets ;Febresta 40mg qd+colchicine 0.5mg qd ;Febuxostat 40mg qd
Affiliated Hospital of Qingdao University; Affiliated Hospital of Qingdao University, Provided by the experimental party
gout
 
 
ChiCTR2200057996: Studies on enzyme activity, metabolomics, gene expression and gene polymorphism of phase I and phase II drug metabolism represented by CYP3A4, UGT and CES in obese people

Not yet recruiting
4
132
 
Sixteen males are planned to be enrolled. Subjects took 2mg midazolam orally on an empty stomach in D1 to detect midazolam concentration ;Sixteen males are planned to be enrolled. Subjects took febuxostat 80mg orally on an empty stomach D1 to detect febuxostat concentration ;A total of 100 healthy subjects were included in the phase 1 clinical trial. 5 ml of venous blood was collected for the detection of drug metabolism enzyme related gene polymorphism, gene expression and metabonomics
Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, Self-raised funds
Obesity
 
 
ChiCTR2300071874: The effect of small molecule alkaline water in combination with febuxostat on serum urate in patients with gout:a randomized, placebo-controlled clinical trial

Recruiting
4
224
 
Febuxostat+Purified Water: Febuxostat 20/40 mg qd +Purified water 6 bottles qd; ;Febuxostat+C-cell vitality water: Febuxostat 20/40 mg qd +C-cell vitality water 6 bottles qd;
The Affiliated Hospital of Qingdao University; The Affiliated Hospital of Qingdao University, Provided by the experimental party
Gout
 
 
ChiCTR2300078984: Randomized, controlled, multicenter clinical study of rebamipide in the prevention of gout attack

Recruiting
4
195
 
Febuxostat 20 mg bid + rebamipide 0.1 g tid; Febuxostat 20 mg bid + colchicine tablets 0.5 mg qd; Febuxostat 20 mg bid
Anqing Hospital Affiliated to Anhui Medical University; Anqing Hospital Affiliated to Anhui Medical University, self-finance
gout
 
 
IRCT20190727044343N1: The effect of febuxostat against lung injury induced by COVID-19 virus in infected patients: A clinical trial study

Active, not recruiting
3
60
Mazandaran
febuxostat - Ipsen, Menarini, Generic mfg.
Ipsen, Menarini, Generic mfg.
COVID-19
 
 
2020-004766-19: Non-inferiority study of a new therapeutic strategy for gout: immediate prescription of a hypouricemia treatment, febuxostat, compared to its deferred administration. Etude de non-infériorité d'une nouvelle stratégie thérapeutique de la goutte : prescription immédiate d'un traitement hypouricémiant, le fébuxostat, comparée à son administration différée

Not yet recruiting
3
128
Europe
ADENURIC, AMM EU/1/08/447/024, Film-coated tablet, ADENURIC (fébuxostat) 80 mg
University Hospital Centre of Rouen, University Hospital Centre of Rouen
Patients with gout attacks Malades atteints d'une crise de goutte, Gout disease Maladie de la goutte, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
NCT05007392: A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

Completed
3
451
RoW
Dotinurad, FYU-981, Febuxostat, Dotinurad Matched Placebo, Febuxostat Matched Placebo
Eisai Co., Ltd.
Gout
06/23
06/23
NCT06139393: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults

Not yet recruiting
3
750
NA
HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets
Jiangsu HengRui Medicine Co., Ltd.
Gout With Hyperuricemia in Adults
11/24
06/25
NCT06414837: Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults

Not yet recruiting
3
434
NA
HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets
Jiangsu HengRui Medicine Co., Ltd.
Gout With Hyperuricemia in Adults
06/26
06/26
FEFACRIGOU, NCT05109936: Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration

Not yet recruiting
3
128
NA
Adenuric
University Hospital, Rouen
Gout
08/25
08/25
EPIC, NCT05815901: A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

Recruiting
3
588
RoW
Epaminurad 6 mg, Epaminurad 9 mg, Febuxostat 40 mg, Febuxostat 80 mg, Epaminurad 6 mg placebo, Epaminurad 9 mg placebo, Febuxostat 40 mg placebo, Febuxostat 80 mg placebo
JW Pharmaceutical
Gout
08/25
08/25
NCT06603142: Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia

Active, not recruiting
2/3
636
RoW
Febuxostat 20MG Tablets, Febuxostat 20MG Placebo, AR882 25MG, AR882 12.5MG, AR882 25MG Placebo, AR882 12.5MG Placebo, Febuxostat 40MG Tablets, Febuxostat 40MG Placebo
Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd
Primary Gout, Hyperuricemia
04/26
04/26
NCT04772352: Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout

Not yet recruiting
2
200
RoW
febuxostat treatment, lifestyle intervention
Ningbo No. 1 Hospital
Nonalcoholic Fatty Liver Disease
08/21
03/22
NCT05513976: Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Not yet recruiting
2
129
NA
SHR4640 tablet, febuxostat tablet, SHR4640 placebo tablet
Jiangsu HengRui Medicine Co., Ltd.
Primary Gout and Hyperuricemia
05/23
09/23
NCT05574036: Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia

Recruiting
2
70
RoW
Febuxostat 80 MG Oral Tablet, Andouristat 80 mg, Staturic 80 mg, vit E, Vitamin E 400 mg
Tanta University
Non Alcoholic Steatohepatitis, Hyperuricemia
05/24
12/24
NCT06501534: A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects

Active, not recruiting
2
84
RoW
Febuxostat, IBI128
Innovent Biologics (Suzhou) Co. Ltd.
Gout, Hyperuricemia
01/25
02/25
ACTRN12617001346369: Single dose study of febuxostat (80 mg) in healthy subjects.

Recruiting
1/2
10
 
St Vincent's Hospital, Sydney, Clinical Pharmacology Lexy Davies Trust Fund
Chronic gout
 
 
ACTRN12612001107819: Febuxostat-thiopurine combination therapy in patients with moderately severe inflammatory bowel disease

Not yet recruiting
1
6
 
Prof Tim Florin
inflammatory bowel disease
 
 
ChiCTR-TTRCC-14004288: Pharmacokinetics and Bioequivalence study of Febuxostat Tablets in Healthy Chinese male Volunteers

Completed
1
24
 
febuxostat(newly developed formulation or established branded formulation)
West China Hospital, Sichuan University; Furuikangzheng Medical Research Institute, primary and secondary sponsor
Pharmacokinetic Properties
 
 
ChiCTR-IIR-16008088: Pharmacokinetics of febuxostat in Chinese healthy volunteers

Completed
1
60
 
In the fasting state, single and multiple oral doses of 40mg firstly, then single and multiple oral doses of 80mg, finally single oral dose of 120mg ;In the fasting state, single and multiple oral doses of 80mg firstly, then single oral dose of 120mg, finally singl and multiple oral doses of 40mg ;In the fasting state, single oral dose of 120mg firstly, then single oral dose of 40mg, finally single and multiple oral doses of 40mg ;Single oral dose of 80mg in the fasting state, then single oral dose of 80mg in the fed state ;Single oral dose of 80mg in the fed state, then single oral dose of 80mg in the fasting state
The first affiliated hospital, School of Medicine, Zhejiang University; Jiang Su Heng Rui Co. LTD, Provided by Jiang Su Heng Rui Co. LTD
gout
 
 
ChiCTR-IIC-16007794: Febuxostat for prevention of cardiovascular, cerebrovascular and renal events in chronic kidney disease patients with hyperuricemia: A Multicenter, prospective, randomized, double blind, placebo-controlled study

Not yet recruiting
1
400
 
febuxostat ;Placebo
Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University; Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Manufacturer Sponsorship
chronic kidney disease patients with hyperuricemia
 
 
NCT05347498: A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults

Not yet recruiting
1
90
NA
HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets
Jiangsu HengRui Medicine Co., Ltd.
Primary Gout With Hyperuricemia in Adults
07/22
07/22
NCT05324423: To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

Recruiting
1
20
RoW
Colchicine, Febuxostat、XNW3009
The Affiliated Hospital of Qingdao University
Gout
08/22
09/22
ChiCTR2200058093: Effect of Jianpi Qushi Recipe on hyperuricemia patients and the serum levels of inflammatory cytokines

Not yet recruiting
1
168
 
Oral Jianpi Qushi prescription + lifestyle adjustment (diet, exercise) ;Oral febuxostat treatment+lifestyle adjustment (diet, exercise)
Tianjin First Central Hospital; Tianjin First Central Hospital, Self-raised
hyperuricemia
 
 
NCT06525974: Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

Not yet recruiting
1
46
NA
Febuxostat, Mesalamine
Tanta University
Ulcerative Colitis
09/26
12/26
NCT06233162: Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Not yet recruiting
1
46
NA
Febuxostat-Test product, Febuxostat-Reference product
Bio-innova Co., Ltd
Healthy Subjects
10/24
10/24
ChiCTR2300070861: Clinical study on Jianpi Zhishui Granules treating gouty nephropathy (spleen deficiency and dampness resistance type)

Not yet recruiting
1
40
 
Oral administration of febuxostat tablets and Jianpi Xiaoshi granules ;Oral febuxostat tablets
The First Affiliated Hospital of Yunnan University of Chinese Medicine; Yunnan Hospital of Traditional Chinese Medicine, Department of Rheumatology, Yunnan Hospital of Traditional Chinese Medicine
gouty nephropathy
 
 
ChiCTR-IOR-14005486: Using Febuxostat for acute attacks of gout: a randomized clinical trial

Recruiting
N/A
120
 
Westen medical treatmentswith uricosuric ;Routine treatment of Westen medicine
The Affiliated Hospital of Qingdao University; The Affiliated Hospital of Qingdao University, Self-reliance
gout
 
 
ChiCTR-TTRCC-13003760: Comparative Fasting Bioavailability of Two Febuxostat Formulations in Healthy Male Chinese Volunteers: An Open-Label, Randomized, Single-Dose, Two-Way Crossover Study

Completed
N/A
24
 
1st period, reference formulation-80mg; 2nd period, test, 80mg ;1st period, test formulation-80mg; 2nd period, reference, 80mg
First Affiliated Hospital, College of Medicine, Zhejiang University; Zhejiang Jianfeng Pharmaceutical Co., Ltd., Zhejiang Jianfeng Pharmaceutical Co., Ltd.
Healthy Volunteers
 
 
ChiCTR1800015962: Study of the Relationship between Urolithic Lower Urinary Acid Treatment and Inflammation Duration in the Acute Phase of Gout

Not yet recruiting
N/A
140
 
Diclofenac 75mg, b.i.d ;Diclofenac 75mg, b.i.d, + Febuxostat 40mg/d
Shenzhen Traditional Chinese Medicine Hospital, the fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen; The Second Affiliated Hospital Guiyang College of Traditional Chinese Medicine, This study was funded by the Sanming Project of Medicine in Shenzhen
Gout
 
 
ChiCTR2000032908: Effects of urine alkalization in gout patients: a prospective, randomized controlled trial

Completed
N/A
200
 
Urine alkalization control drugs sodium bicarbonate were taken for one month at a dose of 3 × 1.0 g/day,at the same time, the uric acid-lowering drug febuxostat tablets was taken (40 mg, qd). ;Urine alkalization control drugs sodium hydrogen citrate were taken for one month at a dose of 3 × 2.5 g/day,at the same time, the uric acid-lowering drug febuxostat tablets was taken (40 mg, qd).
Affiliated Hospital of Qingdao University; Affiliated Hospital of Qingdao University, National key research and development program
Gout
 
 
ChiCTR2000038137: The clinical study of uric acid-lowering therapy for blood pressure control in patients with prehypertension and hyperuricemia

Recruiting
N/A
 
Febuxostat ;Nil
Deyang People's Hospital; Deyang People's Hospital, Health Hommission of Sichuan Provincial
Prehypertension
 
 
ChiCTR2000036918: Evaluation of the clinical efficacy of the comprehensive regimen of traditional Chinese medicine in the treatment of chronic kidney disease with hyperuricemia

Recruiting
N/A
150
 
traditional Chinese medicine ;Febuxostat ;Chinese medicine plus febuxostat group
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai Municipal Health and Family Planning Commission
CKD HUA
 
 
ChiCTR1800020315: Study for the effectiveness of different courses of low-dose colchicine for preventing acute flares during urate lowering therapy by febuxostat

Recruiting
N/A
162
 
4 weeks of low-dose colchicine for preventing ;12 weeks of low-dose colchicine for preventing ;24 weeks of low-dose colchicine for preventing
The Second Affiliated Hospital, Zhejiang University School of Medicine; The Second Affiliated Hospital, Zhejiang University School of Medicine, Self-funding
Gout
 
 
ChiCTR1900028684: Follow-up study for the curative effect of uric acid-reducing treatment in patients with hyperuricemia

Not yet recruiting
N/A
160
 
Treatment with benzbromarone ;Treatment with febuxostat / allopurinol ;Treatment with benzbromarone ;Treatment with febuxostat / allopurinol ;Treatment with benzbromarone ;Treatment with febuxostat / allopurinol ;Treatment with benzbromarone ;Treatment with febuxostat / allopurinol
Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No funding involved
hyperuricemia
 
 
ChiCTR1900025510: Urate-lowering therapy (ULT) on the progression of chronic kidney disease in stages 2–4 patients with hyperuricemia:a prospective, multi-center, open-label clinical study

Recruiting
N/A
288
 
Febuxostat tablets
Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine; Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine, self-raised
CKD stages 2-4 patients with hyperuricemia
 
 
ChiCTR2000038654: Effect of low-dose febuxostat combined with colchicine on acute attack of gouty arthritis

Not yet recruiting
N/A
200
 
Give etoricoxib 120 mg qd*5 days within 72 hours of acute gout attack; Febuxostat 20mg qd+colchicine 0.5mg qd*3 months; For acute attacks of gouty arthritis, start the treatment for 1, 3, 5, 7 days and 2 weeks, 1 month, and 3 months to do the joint pain VAS score, and check the inflammation& ;Give etoricoxib 120 mg qd*5 days within 72 hours of acute gout attack; Colchicine 0.5mg qd*3 months; Acute onset of gout, pain relief for 2 weeks, start to give febuxostat 20mg qd to 3 months; For acute attacks of gouty arthritis, start treatment for 1, 3, 5, 7 days, and 2 weeks, 1 month
Center for Endocrine Metabolism and Immune Diseases, Luhe Hospital, Capital Medical University; Center for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Center for Endocrine Metabolism and Immune Diseases, Luhe Hospital, Capital Medical University
gout
 
 
ChiCTR2000036866: A clinical study on precise intervention of ocular uric acid based on metabonomics for diabetic retinopathy

Not yet recruiting
N/A
60
 
Control ;benzene bromine Malone ;Febuxostat
Shanghai General Hospital; Shanghai General Hospital, Scientific research project funds
Diabetic retinopathy
 
 
ChiCTR2200061620: Decrease in serum urate level is associated with decrease of blood pressure in young adults gout patients: a prospective, randomized controlled trial

Recruiting
N/A
400
 
Febuxostat 20~80 mg/day or benzbromarone 25~50 mg/day while without anti-hypertension drugs ;Without urate-lowering therapy while without anti-hypertension drugs
the Affiliated Hospital of Qingdao University; the Affiliated Hospital of Qingdao University, National Natural Science Foundation of China (81900636、81770869)
Gout
 
 
ChiCTR2200056024: Clinical observation of Jianpi Bushen Xiezhuo fang decoction for the intermittent gout patients with Pixu Shizhu zheng

Not yet recruiting
N/A
90
 
Jianpi Bushen Xiezhuo Fang ;Febuxostat ;benzbromarone
Chongqing Hospital of Traditional Chinese Medicine; Chongqing Hospital of Traditional Chinese Medicine, Scientific research project of Chongqing Health and Family Planning Commission
gout
 
 
ChiCTR2100049048: A randomized controlled trial evaluating the jiangniaosuan formulation as a treatment for hyperuricemic nephropathy at CKD stages 3-4 patients

Not yet recruiting
N/A
118
 
Jiangniaosuan formulation+Febuxostat+Basic treatment ;Febuxostat+Basic treatment
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Science and Technology Commission of Shanghai Municipality
hyperuricemic nephropathy at CKD stages 3-4
 
 
ChiCTR2300073394: Clinical Intervention Trial of Decreasing Uric Acid and Protecting Kidney in Healthy Physical Examiners with Hyperuricemia

Not yet recruiting
N/A
100
 
Control group: Participants were instructed to maintain a healthy lifestyle and limit their intake of high purine diets. A follow-up examination was conducted after twelve weeks. After reexamination, it is recommended that patients receive clinical standardized treatment for those who meet clinical treatment standards. ;Intervention group: 1. According to the "Chinese HUA and Gout Diagnosis and Treatment Guidelines (2019)" , guide all SUA > 420 μmol/L. Patients with mol/L maintain a healthy lifestyle, including weight control, limiting alcohol and high purine and fructose intake; Encourage the intake of dairy products, vegetables, and moderate drinking water; Do not recommend or limit the intake of soy products. 2. Patient's blood uric acid level > 540 μmol/L, use Febuxostat, the initial dose is 20 mg/time, once a day, and recheck for 2 weeks. According to the blood uric acid value, 20 mg/time can be increased, and the maximum daily dose is 80mg. Take continuously for 4 weeks. The goal is to control blood uric acid levels below 420 μmol/L. 3. Patients with a morning urine pH value of < 6.0 should take sodium bicarbonate at a dose of 1 g/time, twice a day, and drink no less than 2000mL of water per day. It is recommended to use a simple urine pH meter to self monitor the urine pH value, with the goal of maintaining the urine pH between 6.2 and 6.9. If self monitoring is not possible, the urine pH value should be rechecked at least every two weeks. 4. Regular follow-up, including blood uric acid levels and urine pH value. 5. According to the usual onset time of clinical uric acid lowering therapy, this intervention trial lasts for 42 weeks. Check and record all indicators before and after intervention, and keep two urine samples. The intervention experiment is over, and all clinical work continues according to diagnostic and treatment standards.
Xuzhou Central Hospital; Xuzhou Central Hospital, National Natural Science Foundation of China (82070854)
Renal Injury
 
 
ChiCTR2100045183: The effect of alkalized urine on kidney stones in patients with gout: a randomized controlled double-blind trial

Recruiting
N/A
98
 
Sodium Bicarbonate + Febuxostat ;Placebo+Sodium Bicarbonate + Febuxostat
Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine; Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, The Sanming Project of Medicine in Shenzhen
gout
 
 
ChiCTR2300071056: Clinical Observation on the Therapeutic Effect of Jianpi Shenshi Granule on Gout Stone (Spleen Deficiency and Dampness Resistance Type)

Not yet recruiting
N/A
40
 
Febuxostat + Jianpi Shenshi Granule ;Febuxostat
The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine; The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Base funds
Gout Stone
 
 
NCT04697602: Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout

Terminated
N/A
21
RoW
Stepwise dose titration of febuxostat and low-dose colchicine, Fixed dose febuxostat and low-dose colchicine
National Taiwan University Hospital, National Taiwan University Hospital, Yun-Lin Branch
Gout
08/23
08/23
ChiCTR2200060680: A double-blind randomized controlled trial of Qizhi Tongfeng Granule in the treatment of chronic refractory gout

Not yet recruiting
N/A
40
 
Febuxostat tablet 40mg once a day + Qizhi Gout granules, 1 dose a day, divided into 2 times, orally. ;Febuxostat tablet 40mg once a day + Qizhi gout granule placebo, 1 dose, 2 times a day, orally.
Fangshan Hospital Affiliated to Beijing University of Chinese Medicine; Fangshan Hospital Affiliated to Beijing University of Chinese Medicine, Capital Health development Scientific Research Independent innovation Project
Gout
 
 
ChiCTR2400083067: A randomized controlled trial of Qizhi gout granule in the treatment of patients with chronic gout

Not yet recruiting
N/A
80
 
"Qizhi gout granules" decoction, one dose daily, divided into two administrations, taken orally.; Febuxostat tablet 20mg once a day
Fangshan Hospital Affiliated to Beijing University of Chinese Medicine; Fangshan Hospital Affiliated to Beijing University of Chinese Medicine, Beijing University of Chinese Medicine New Faculty start-up Fund project
Gout
 
 
ChiCTR2300073188: Clinical and Mechanism Study on Qifu Huazhuo Formula in Treating intercritical gout and chronic gouty arthritis

Recruiting
N/A
90
 
Febuxostat (40mg/dose, once daily, oral); Qifu Huazhuo Formula (250ml/time, twice a day, oral); Febuxostat (40mg/dose, once daily, oral)+Qifu Huazhuo Formula (250ml/dose, twice daily, oral)
Guangdong Provincial Hospital of Chinese Medicine; Zhuhai Hospital of Guangdong Provincial Hospital of Traditional Chinese Medicine, raise independently
gout
 
 
ChiCTR2300071108: Clinical observation and network pharmacological analysis of modified Simiao Decoction in the treatment of damp-heat intrinsic gout

Not yet recruiting
N/A
120
 
Febuxostat was taken orally 20mg/ day for 24 weeks ;Modified Simiao Decoction 100ml morning and evening 2 times oral; Meanwhile, febuxostat was taken orally 20mg/ day in combination. All took the drug for 24 weeks.
Shanghai Changning Tianshan Traditional Chinese Medicine Hospital; Science and Technology Commission of Changning District of Shanghai, Appropriated by Science and Technology Commission of Changning District, Shanghai. Matching Funds of Shanghai Changning Tianshan Traditional Chinese Medicine Hospital
Gout
 
 
ChiCTR2400084417: Quzhuo Tongbi Formula prevents gout flares in the process of ULT A randomized controlled clinical trial

Not yet recruiting
N/A
144
 
Quzhuo Tongbi Granules+Febuxostat; Chinese herbal placebo+Febuxostat
Zhejiang Chinese Medical University; Zhejiang Chinese Medical University, GK2024 Provincial Traditional Chinese Medicine Research Project (24-134)
gout
 
 
NCT04799925: Hyperuricemia and Diabetic Nephropathy

Not yet recruiting
N/A
200
NA
Febuxostat
Assiut University
Hyperuricemia, Diabetic Nephropathies
04/22
12/22

Download Options